# SRAM study_Postate Cancer

> **NCT03938649** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **CCTU** · enrollment: 120 (estimated)

## Conditions studied

- Advanced Prostate Cancer

## Interventions

- **RADIATION:** Conventional IMRT
- **DRUG:** SBRT

## Key facts

- **NCT ID:** NCT03938649
- **Lead sponsor:** CCTU
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03938649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03938649, "SRAM study_Postate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03938649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*